Furthermore, these components were found to target proteins such as PTGS2, TNF, TGFB1, BCL2, TP53, IL10, JUN, MMP2, IL1B and MYC, suggesting their potential as therapeutic targets for schistosomiasis treatment. Here, IL1B is linked to schistosomiasis.